Ledger.Open graph →
SEC Form D · filed April 3, 2023

Encentrio Therapeutics, Inc

Offering
$400K
Sold
$400K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Thomas Hecht · Fremont, CADirectorGeorge Scangos · San Francisco, CADirectorSung Lee · Allen, TXExec · DirectorJohanna Friedl-Naderer · San Francisco, CADirectorNatascha Schill · San Francisco, CAExec · DirectorVanina De Verneuil · San Francisco, CAExecThomas Hecht · Fremont, CADirectorGeorge Scangos · San Francisco, CADirectorSung Lee · Allen, TXExec · DirectorJohanna Friedl-Naderer · San Francisco, CADirectorNatascha Schill · San Francisco, CAExec · DirectorVanina De Verneuil · San Francisco, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗